Liquim Pty Ltd announces the appointment of Dr Clay Golledge as Chief Medical Advisor.

“We are happy to announce the appointment of Dr Golledge as a great addition to our Western Australian based medical biotechnology company”, says Sheryl Frame, Liquim’ s Chief Business Development Officer (CBDO).

Clay is a well-known Physician in Infection Management and a Clinical Microbiologist with 30 years of consultant experience. Dr Golledge completed his training at Royal Perth, Sir Charles Gairdner, and Fremantle Hospitals. He underwent advanced training in Infectious Diseases at the City Hospital and Western General Hospital in Edinburgh and from 1991 to 2018 was a consultant at Sir Charles Gairdner Hospital.

He now runs Infections West, Perth’s largest and most progressive Infectious Disease practice. Dr Golledge admits and consults at Hollywood Private Hospital.

He authored over 130 scientific papers, four book chapters and was a regular guest expert on TV and radio.

MEDIA ENQUIRIES:                                                                                     

Name:                      Amanda Houghton

Position:                  Media Liaison

Mobile:                     0418 908 350

Email:                       media@liquim.com.au

Email:                       enquiries@liquim.com.au

DISCLOSURE:         This Announcement was authorised for release by CEO, Velimir Pajic.